Works by Baohui Han

Results: 213

Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations.

Published in:

2016

By:

Zhang Yanwei;
Jin Bo;
Lou Yuqing;
Li Rong;
Zhang Xueyan;
Hu Song;
Han Baohui;
Yanwei, Zhang;
Bo, Jin;
Yuqing, Lou;
Rong, Li;
Xueyan, Zhang;
Song, Hu;
Baohui, Han

Publication type:

journal article

A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Published in:

2018

By:

Chih-Hsin Yang, James;
Mok, Tony;
Baohui Han;
Orlando, Mauro;
Puri, Tarun;
Park, Keunchil;
Yang, James Chih-Hsin;
Han, Baohui

Publication type:

journal article

High-resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid Nodules.

Published in:

2018

By:

Wenjia Yang;
Yifeng Sun;
Wentao Fang;
Fangfei Qian;
Jianding Ye;
Qunhui Chen;
Yifeng Jiang;
Keke Yu;
Baohui Han;
Yang, Wenjia;
Sun, Yifeng;
Fang, Wentao;
Qian, Fangfei;
Ye, Jianding;
Chen, Qunhui;
Jiang, Yifeng;
Yu, Keke;
Han, Baohui

Publication type:

journal article

Third‐line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double‐blind phase 2 study.

Published in:

Cancer Innovation, 2023, v. 2, n. 3, p. 181, doi. 10.1002/cai2.43

By:

Cheng, Ying;
Wang, Qiming;
Li, Kai;
Shi, Jianhua;
Han, Baohui;
Wu, Lin;
Chen, Gongyan;
He, Jianxing;
Wang, Jie;
Qin, Haifeng;
Li, Xiaoling

Publication type:

Article

Characteristics and clinical outcomes of patients with lung cancer requiring ICU admission: a retrospective analysis based on the MIMIC-III database.

Published in:

Emergency Cancer Care, 2023, v. 2, n. 1, p. 1, doi. 10.1186/s44201-022-00017-2

By:

Qian, Jie;
Qin, Ruoyan;
Hong, Liang;
Shi, Yangyang;
Yuan, Haibin;
Zhang, Bo;
Nie, Wei;
Li, Yanwen;
Han, Baohui

Publication type:

Article

Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2024, v. 29, n. 7, p. e932, doi. 10.1093/oncolo/oyae052

By:

Xu, Yingqi;
Ji, Hao;
Zhang, Yidan;
Xiong, Liwen;
Han, Baohui;
Zhong, Hua;
Xu, Jianlin;
Zhong, Runbo

Publication type:

Article

The Impact of Anlotinib on Brain Metastases of Non‐Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).

Published in:

Oncologist, 2020, v. 25, n. 5, p. e870, doi. 10.1634/theoncologist.2019-0838

By:

Jiang, Shunjun;
Liang, Hengrui;
Liu, Zhichao;
Zhao, Shen;
Liu, Jun;
Xie, Zhanhong;
Wang, Wei;
Zhang, Yalei;
Han, Baohui;
He, Jianxing;
Liang, Wenhua

Publication type:

Article

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study.

Published in:

Oncologist, 2019, v. 24, n. 2, p. 157, doi. 10.1634/theoncologist.2018-0120

By:

Xiong, Liwen;
Li, Rong;
Sun, Jiayuan;
Lou, Yuqing;
Zhang, Weiyan;
Bai, Hao;
Wang, Huiming;
Shen, Jie;
Jing, Bo;
Shi, Chunlei;
Zhong, Hua;
Gu, Aiqin;
Jiang, Liyan;
Shi, Jianxing;
Fang, Wentao;
Zhao, Heng;
Zhang, Jie;
Wang, Junyuan;
Ye, Junyi;
Han, Baohui

Publication type:

Article

On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1173025

By:

Anning Xiong;
Jianlin Xu;
Shuyuan Wang;
Runbo Zhong;
Jun Lu;
Tianqing Chu;
Wei Zhang;
Ying Li;
Xiaoxuan Zheng;
Baohui Han;
Wei Nie;
Hua Zhong;
Xueyan Zhang

Publication type:

Article

Efficacy of ICI-based treatment in advanced NSCLC patients with PD-L1=50% who developed EGFR-TKI resistance.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161718

By:

Yujing Li;
Haohua Jiang;
Fangfei Qian;
Ya Chen;
Wensheng Zhou;
Yanwei Zhang;
Jun Lu;
Yuqing Lou;
Baohui Han;
Wei Zhang

Publication type:

Article

Gprc5a -deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway.

Published in:

Cell Cycle, 2015, v. 14, n. 9, p. 1403, doi. 10.1080/15384101.2015.1006006

By:

Liao, Yueling;
Song, Hongyong;
Xu, Dongliang;
Jiao, Huike;
Yao, Feng;
Liu, Jingyi;
Wu, Yadi;
Zhong, Shuangshuang;
Yin, Huijing;
Liu, Shuli;
Wang, Xiaofei;
Guo, Wenzheng;
Sun, Beibei;
Han, Baohui;
Chin, Y. Eugene;
Deng, Jiong

Publication type:

Article

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study.

Published in:

2021

By:

Cheng, Ying;
Wang, Qiming;
Li, Kai;
Shi, Jianhua;
Liu, Ying;
Wu, Lin;
Han, Baohui;
Chen, Gongyan;
He, Jianxing;
Wang, Jie;
Lou, Donghua;
Yu, Hao;
Wang, Shanchun;
Qin, Haifeng;
Li, Xiaoling

Publication type:

journal article

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).

Published in:

2018

By:

Han, Baohui;
Li, Kai;
Zhao, Yizhuo;
Li, Baolan;
Cheng, Ying;
Zhou, Jianying;
Lu, You;
Shi, Yuankai;
Wang, Zhehai;
Jiang, Liyan;
Luo, Yi;
Zhang, Yiping;
Huang, Cheng;
Li, Qiang;
Wu, Guoming

Publication type:

journal article

Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer.

Published in:

FASEB Journal, 2022, v. 36, n. 8, p. 1, doi. 10.1096/fj.202101658R

By:

Jun Lu;
Wei Zhang;
Keke Yu;
Lele Zhang;
Yuqing Lou;
Ping Gu;
Wei Nie;
Jie Qian;
Jun Xu;
Huimin Wang;
Hua Zhong;
Baohui Han

Publication type:

Article

Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.

Published in:

Cancer Science, 2012, v. 103, n. 8, p. 1451, doi. 10.1111/j.1349-7006.2012.02323.x

By:

Gu, Shaohua;
Wu, Qihan;
Zhao, Xueying;
Wu, Wenting;
Gao, Zhiqiang;
Tan, Xiaoming;
Qian, Ji;
Chen, Hongyan;
Xie, Yi;
Jin, Li;
Han, Baohui;
Lu, Daru

Publication type:

Article

Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 1, p. 293, doi. 10.1007/s00520-014-2376-z

By:

Kim, Hoon-Kyo;
Hsieh, RueyKuen;
Chan, Alexandre;
Yu, Shiying;
Han, Baohui;
Gao, Yunong;
Baños, Ana;
Ying, Xiaoyan;
Burke, Thomas;
Keefe, Dorothy

Publication type:

Article

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.

Published in:

Supportive Care in Cancer, 2014, v. 22, n. 4, p. 979, doi. 10.1007/s00520-013-2043-9

By:

Hu, Zhihuang;
Cheng, Ying;
Zhang, Hongyu;
Zhou, Caicun;
Han, Baohui;
Zhang, Yiping;
Huang, Cheng;
Chang, Jianhua;
Song, Xiangqun;
Liang, Jun;
Liang, Houjie;
Bai, Chunxue;
Yu, Shiying;
Chen, Jia;
Wang, Jie;
Pan, Hongming;
Chitkara, Denesh;
Hille, Darcy;
Zhang, Li

Publication type:

Article

Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming.

Published in:

Advanced Therapeutics, 2023, v. 6, n. 11, p. 1, doi. 10.1002/adtp.202300141

By:

Zou, Benkun;
Jiang, Haohua;
Liu, Hongyu;
Lu, Jun;
Qiang, Huiping;
Lu, Mingfang;
Yu, Lian;
Zhong, Hua;
Chu, Tianqing;
Han, Baohui

Publication type:

Article

Association Between CASP8 and CASP10 Polymorphisms and Toxicity Outcomes With Platinum-Based Chemotherapy in Chinese Patients With Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2012, v. 17, n. 12, p. 1551, doi. 10.1634/theoncologist.2011-0419

By:

Ji Qian;
Hui-Qi Qu;
Lixin Yang;
Ming Yin;
Qiming Wang;
Shaohua Gu;
Qihan Wu;
Xueying Zhao;
Wenting Wu;
Junjie Wu;
Xiaoming Tan;
Wenqing Chen;
Haijian Wang;
Jiucun Wang;
Weiwei Fan;
Hongyan Chen;
Baohui Han;
Daru Lu;
Qingyi Wei;
Li Jin

Publication type:

Article

Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case–Control Study.

Published in:

Biomedicines, 2023, v. 11, n. 6, p. 1549, doi. 10.3390/biomedicines11061549

By:

Qiao, Rong;
Sang, Siyao;
Teng, Jiajun;
Zhong, Hua;
Li, Hui;
Han, Baohui

Publication type:

Article

Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients.

Published in:

Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00400-5

By:

Lu, Jun;
Wu, Jun;
Lou, Yuqing;
Shi, Qin;
Xu, Jun;
Zhang, Lele;
Nie, Wei;
Qian, Jie;
Wang, Yanan;
Zhang, Yanwei;
Jiao, Jing;
Zhang, Xueyan;
Zhang, Wei;
Wang, Huimin;
Chu, Tianqing;
Zhong, Hua;
Han, Baohui

Publication type:

Article

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.

Published in:

Cancer Medicine, 2020, v. 9, n. 8, p. 2621, doi. 10.1002/cam4.2913

By:

Cheng, Ying;
Han, Baohui;
Li, Kai;
Wang, Qiming;
Zhang, Li;
Shi, Jianhua;
Wang, Zhehai;
He, Jianxing;
Shi, Yuankai;
Chen, Weiqiang;
Wang, Xiuwen;
Luo, Yi;
Nan, Kejun;
Jin, Faguang;
Li, Baolan;
Zhu, Jing

Publication type:

Article

RGB and HSV quantitative analysis of autofluorescence bronchoscopy used for characterization and identification of bronchopulmonary cancer.

Published in:

Cancer Medicine, 2016, v. 5, n. 11, p. 3023, doi. 10.1002/cam4.831

By:

Zheng, Xiaoxuan;
Xiong, Hongkai;
Li, Yong;
Han, Baohui;
Sun, Jiayuan

Publication type:

Article

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.745150

By:

Qian, Jie;
Wang, Weimin;
Wang, Lin;
Lu, Jun;
Zhang, Lele;
Zhang, Bo;
Wang, Shuyuan;
Nie, Wei;
Zhang, Yanwei;
Lou, Yuqing;
Han, Baohui

Publication type:

Article

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.714549

By:

Wang, Yanan;
Qian, Fangfei;
Chen, Ya;
Yang, Zhengyu;
Hu, Minjuan;
Lu, Jun;
Zhang, Yanwei;
Zhang, Wei;
Cheng, Lei;
Han, Baohui

Publication type:

Article

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.675354

By:

Yu, Lian;
Xu, Jianlin;
Qiao, Rong;
Zhong, Hua;
Han, Baohui;
Zhong, Runbo

Publication type:

Article

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.681429

By:

Yang, Zhengyu;
Chen, Ya;
Wang, Yanan;
Wang, Shuyuan;
Hu, Minjuan;
Zhang, Bo;
Han, Baohui

Publication type:

Article

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.691519

By:

Chen, Ya;
Wang, Yanan;
Yang, Zhengyu;
Hu, Minjuan;
Zhang, Yanwei;
Qian, Fangfei;
Zhang, Wei;
Zhang, Bo;
Han, Baohui

Publication type:

Article

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.665484

By:

Zhao, Yiming;
Wang, Shuyuan;
Yang, Zhengyu;
Dong, Yu;
Wang, Yanan;
Zhang, Lele;
Hu, Hai;
Han, Baohui

Publication type:

Article

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.671228

By:

Chen, Ya;
Yang, Zhengyu;
Wang, Yanan;
Hu, Minjuan;
Zhang, Bo;
Zhang, Yanwei;
Qian, Fangfei;
Zhang, Wei;
Han, Baohui

Publication type:

Article

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.652560

By:

Chang, Qing;
Qiang, Huiping;
Qian, Jialin;
Lei, Yuqiong;
Lu, Jiahuan;
Feng, Hui;
Zhao, Yiming;
Han, Baohui;
Zhang, Yanwei;
Chu, Tianqing

Publication type:

Article

Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.556194

By:

Shen, Yinchen;
Hu, Fang;
Li, Changhui;
Xu, Jianlin;
Zhong, Runbo;
Zhang, Xueyan;
Chu, Tianqing;
Han, Baohui

Publication type:

Article

Efficacy and tolerability of crizotinib in the treatment of ALK-positive, advanced non-small cell lung cancer in Chinese patients.

Published in:

Medical Oncology, 2015, v. 32, n. 6, p. 1, doi. 10.1007/s12032-015-0626-7

By:

Cui, Shaohua;
Zhao, Yizhuo;
Gu, Aiqin;
Ge, Xiaoxiao;
Song, Yanyan;
Zhang, Wei;
Lou, Yuqing;
Dong, Lili;
Han, Baohui;
Jiang, Liyan

Publication type:

Article

Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.

Published in:

Medical Oncology, 2015, v. 32, n. 5, p. 1, doi. 10.1007/s12032-015-0583-1

By:

Chang, Jianhua;
Liu, Yunpeng;
Han, Baohui;
Zhou, Caicun;
Bai, Chunxue;
Li, Jin

Publication type:

Article

Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma.

Published in:

Medical Oncology, 2015, v. 32, n. 4, p. 1, doi. 10.1007/s12032-015-0515-0

By:

Lou, Yuqing;
Li, Rong;
Liu, Jielin;
Zhang, Yanwei;
Zhang, Xueyan;
Jin, Bo;
Liu, Ya;
Wang, Zuoguang;
Zhong, Hua;
Wen, Shaojun;
Han, Baohui

Publication type:

Article

Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.

Published in:

Medical Oncology, 2015, v. 32, n. 4, p. 1, doi. 10.1007/s12032-014-0462-1

By:

Zhang, Xueyan;
Lou, Yuqing;
Wang, Huimin;
Zheng, Xiaoxuan;
Dong, Qianggang;
Sun, Jiayuan;
Han, Baohui

Publication type:

Article

Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions.

Published in:

Medical Oncology, 2011, v. 28, n. 3, p. 689, doi. 10.1007/s12032-010-9534-z

By:

Li, Rong;
Wu, Jing;
Ma, Meili;
Pei, Jun;
Song, Yiyi;
Zhang, Xueyan;
Han, Baohui

Publication type:

Article

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.

Published in:

BMC Medical Genomics, 2019, v. 12, n. 2, p. N.PAG, doi. 10.1186/s12920-019-0482-y

By:

Lu, Jun;
Xu, Wei;
Qian, Jie;
Wang, Shuyuan;
Zhang, Bo;
Zhang, Lele;
Qiao, Rong;
Hu, Minjuan;
Zhao, Yiming;
Zhao, Xiaodong;
Han, Baohui

Publication type:

Article

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients.

Published in:

Journal of International Medical Research, 2020, v. 48, n. 4, p. 1, doi. 10.1177/0300060519887275

By:

Liwen Xiong;
Yuqing Lou;
Hao Bai;
Rong Li;
Jinjing Xia;
Wentao Fang;
Jie Zhang;
Han Han-Zhang;
Analyn Lizaso;
Bing Li;
Aiqin Gu;
Baohui Han

Publication type:

Article

Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation.

Published in:

2021

By:

Li, Changhui;
Nie, Wei;
Guo, Jingdong;
Xiong, Anning;
Zhong, Hua;
Chu, Tianqing;
Zhong, Runbo;
Xu, Jianlin;
Lu, Jun;
Zheng, Xiaoxuan;
Zhang, Bo;
Shen, Yinchen;
Pan, Feng;
Han, Baohui;
Zhang, Xueyan

Publication type:

journal article

Hsa-miR-196a2 Functional SNP is Associated With Severe Toxicity After Platinum-Based Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients in a Chinese Population.

Published in:

Journal of Clinical Laboratory Analysis, 2012, v. 26, n. 6, p. 441, doi. 10.1002/jcla.21544

By:

Zhan, Xiaoying;
Wu, Wenting;
Han, Baohui;
Gao, Ge;
Qiao, Rong;
Lv, Juan;
Zhang, Shuyu;
Zhang, Wei;
Fan, Weiwei;
Chen, Hongyan;
Zhang, Tianbao;
Gu, Aiqin;
Shen, Jie;
Wu, Qihan;
Lu, Daru

Publication type:

Article

The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema.

Published in:

Respiration, 2019, v. 97, n. 5, p. 416, doi. 10.1159/000494327

By:

Li, Shiyue;
Wang, Guangfa;
Wang, Changhui;
Gao, Xinglin;
Jin, Faguang;
Yang, Huaping;
Han, Baohui;
Zhou, Rui;
Chen, Chengshui;
Chen, Liangan;
Bai, Chunxue;
Shen, Huahao;
Herth, Felix J.F.;
Zhong, Nanshan

Publication type:

Article

Navigation Bronchoscopy-Guided Radiofrequency Ablation for Nonsurgical Peripheral Pulmonary Tumors.

Published in:

Respiration, 2017, v. 94, n. 3, p. 293, doi. 10.1159/000477764

By:

Xie, Fangfang;
Zheng, Xiaoxuan;
Xiao, Bo;
Han, Baohui;
Herth, Felix J.F.;
Sun, Jiayuan

Publication type:

Article

Endobronchial Ultrasound Elastography for Evaluation of Intrathoracic Lymph Nodes: A Pilot Study.

Published in:

Respiration, 2017, v. 93, n. 5, p. 327, doi. 10.1159/000464253

By:

Sun, Jiayuan;
Zheng, Xiaoxuan;
Mao, Xiaowei;
Wang, Lei;
Xiong, Hongkai;
Herth, Felix J.F.;
Han, Baohui

Publication type:

Article

Wnt blockers inhibit the proliferation of lung cancer stem cells.

Published in:

Drug Design, Development & Therapy, 2015, v. 9, p. 2399, doi. 10.2147/DDDT.S76602

By:

Xueyan Zhang;
Yuqing Lou;
Xiaoxuan Zheng;
Huimin Wang;
Jiayuan Sun;
Qianggang Dong;
Baohui Han

Publication type:

Article

MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer.

Published in:

PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150467

By:

Li, Rong;
Pu, Xia;
Chang, Joe Y.;
Ye, Yuanqing;
Komaki, Ritsuko;
Minna, John D.;
Roth, Jack A.;
Han, Baohui;
Wu, Xifeng

Publication type:

Article

The Advent of Ultra-high Volume Thoracic Surgical Centers in Shanghai.

Published in:

World Journal of Surgery, 2017, v. 41, n. 11, p. 2758, doi. 10.1007/s00268-017-4086-4

By:

Sihoe, Alan;
Han, Baohui;
Yang, Timothy;
Pan, Changqing;
Jiang, Gening;
Fang, Vincent

Publication type:

Article

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis.

Published in:

2020

By:

Chen, Ya;
Wang, Shuyuan;
Zhang, Bo;
Zhao, Yiming;
Zhang, Lele;
Hu, Minjuan;
Zhang, Wei;
Han, Baohui

Publication type:

journal article

Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.

Published in:

2020

By:

Lou, Yuqing;
Xu, Jianlin;
Zhang, Yanwei;
Lu, Jun;
Chu, Tianqing;
Zhang, Xueyan;
Wang, Huimin;
Zhong, Hua;
Zhang, Wei;
Han, Baohui

Publication type:

journal article

Correction to: Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma.

Published in:

2019

By:

Li, Changhui;
Zhang, Bo;
Guo, Jindong;
Hu, Fang;
Nie, Wei;
Zheng, Xiaoxuan;
Wang, Lixin;
Lou, Yuqing;
Shen, Yinchen;
Han, Baohui;
Zhang, Xueyan

Publication type:

corrected article